These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12454228)

  • 1. Inflammation and pruritus in haemodialysis patients.
    Virga G; Visentin I; La Milia V; Bonadonna A
    Nephrol Dial Transplant; 2002 Dec; 17(12):2164-9. PubMed ID: 12454228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and pruritus in hemodialysis patients.
    Razeghi E; Tavakolizadeh S; Ahmadi F
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):62-6. PubMed ID: 18087125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
    Braun J; Lindner K; Schreiber M; Heidler RA; Hörl WH
    Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodialysis patients.
    Kalender B; Mutlu B; Ersöz M; Kalkan A; Yilmaz A
    Int J Clin Pract; 2002 Sep; 56(7):505-8. PubMed ID: 12296612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of the intensity of uremic pruritus in patients receiving maintenance hemodialysis: A cross-sectional study.
    Zhao JH; Zhu QS; Li YW; Wang LL
    PLoS One; 2021; 16(1):e0245370. PubMed ID: 33471852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Resistance and Hepatitis C Virus-Associated Subclinical Inflammation Are Hidden Causes of Pruritus in Egyptian Hemodialysis Patients: A Multicenter Prospective Observational Study.
    Abdelsalam M; Tawfik M; Reda EM; Eldeeb AA; Abdelwahab A; Zaki ME; Abdelkader Sobh M
    Nephron; 2019; 143(2):120-127. PubMed ID: 31311030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J; Andrade S; Ventura H; Santos JP; Colaço S; Oliveira C; Ponce P
    Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itchy skin--a clinical problem for haemodialysis patients.
    Wikström B
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v3-7. PubMed ID: 17586843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Transferrin Levels Predict Haemodialysis Adequacy in Patients with End-Stage Renal Disease?
    Tarantino G; Vinciguerra M; Ragosta A; Citro V; Conforti P; Salvati G; Sorrentino A; Barretta L; Balsano C; Capone D
    Nutrients; 2019 May; 11(5):. PubMed ID: 31137583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
    Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
    Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
    Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
    Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis.
    Cullen P; Söffker J; Höpfl M; Bremer C; Schlaghecken R; Mehrens T; Assmann G; Schaefer RM
    Nephrol Dial Transplant; 1999 Mar; 14(3):659-65. PubMed ID: 10193816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients.
    Zanen AL; Adriaansen HJ; van Bommel EF; Posthuma R; Th de Jong GM
    Nephrol Dial Transplant; 1996 May; 11(5):820-4. PubMed ID: 8671901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients.
    Canavese C; Bergamo D; Ciccone G; Burdese M; Maddalena E; Barbieri S; Thea A; Fop F
    Nephrol Dial Transplant; 2004 Jun; 19(6):1564-70. PubMed ID: 15004263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study.
    Basile C; Giordano R; Montanaro A; De Maio PD; De Padova FD; Marangi AL; Semeraro A
    Nephrol Dial Transplant; 2001 Sep; 16(9):1914-9. PubMed ID: 11522879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
    Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
    PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between haemoglobin level and all-cause mortality in haemodialysis patients: the link with inflammation and malnutrition.
    Selim G; Stojceva-Taneva O; Sikole A; Amitov V; Trajcevska L; Asani A; Trojacanec-Piponska S; Polenakovic M
    Prilozi; 2007 Jul; 28(1):81-95. PubMed ID: 17921920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications.
    Fallahzadeh MK; Roozbeh J; Geramizadeh B; Namazi MR
    Nephrol Dial Transplant; 2011 Oct; 26(10):3338-44. PubMed ID: 21372257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
    Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
    Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.